PLA2G6 and Parkinson disease: Defining the penetrance of PLA2G6 mutations in PARK14-linked Parkinsonism patients is complicated by the age of onset, that can vary widely among patients (8–37 years) and within families [3, 8, 9], which could lead to pseudo-incomplete penetrance.